Cytokinetics aficamten shows cardiac benefits in two HCM trial analyses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. QQQ
8. UNFI
9. SPY
10. ASO

Go back to Cytokinetics aficamten shows cardiac benefits in two HCM trial analyses
CYTOKINETICS (NASDAQ: CYTK) Delayed: 75.35 --0 (-0%)
Previous Close $75.35    52 Week High $13.18 
Open $75.35    52 Week Low $6.00 
Day High $75.35    P/E N/A 
Day Low $75.35    EPS $-1.24 
Volume 360